Prot #CDFV890B12201: A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-Blinded Study Investigating the Efficacy, Safety and Tolerability of DFV890 in Patients with Symptomatic Knee Osteoarthritis

Project: Research project

Project Details

StatusActive
Effective start/end date4/1/21 → 5/12/27

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CDFV890B12201)